Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,881
Total Claims
$1.6M
Drug Cost
729
Beneficiaries
$2,141
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+82%
Cost per patient vs peers
$2,141 vs $1,174 avg
+76%
Brand preference vs peers
15.6% vs 8.9% avg
Brand vs Generic
Brand: 1,645 claims · $1.4M
Generic: 8,891 claims · $174K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 122 | $214K |
| Linaclotide | 128 | $119K |
| Apixaban | 66 | $92K |
| Empagliflozin | 50 | $90K |
| Sitagliptin Phos/Metformin Hcl | 52 | $89K |
| Icosapent Ethyl | 79 | $70K |
| Dapagliflozin Propanediol | 40 | $69K |
| Semaglutide | 36 | $47K |
| Semaglutide | 14 | $43K |
| Diclofenac Sodium | 16 | $41K |
| Rivaroxaban | 22 | $39K |
| Sitagliptin Phos/Metformin Hcl | 24 | $34K |
| Fluticasone Propion/Salmeterol | 58 | $32K |
| Budesonide/Formoterol Fumarate | 72 | $30K |
| Dulaglutide | 26 | $27K |
Prescribing Profile
Patient Profile
75
Avg Age
58%
Female
1.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data